Latest Trials


EudraCT Number: 2008-002774-34 Sponsor Protocol Number: A2581172 Start Date:
Sponsor Name: Pfizer Inc,235 East 42nd Street,New York,NY 10017
Full Title: A 8-WEEK, OPEN-LABEL, PHASE 1 STUDY TO EVALUATE PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND TOLERABILITY OF ATORVASTATIN IN CHILDREN AND ADOLESCENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Medical condition: HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Disease: Version SOC Term Classification Code Term Level
9.1 10057079 Heterozygous familial hypercholesterolemia LLT
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: NL (Not Authorised) Outside EU/EEA
Trial results: View results

EudraCT Number: 2009-009597-27 Sponsor Protocol Number: BAY86-4875/91743 Start Date:
Sponsor Name: Bayer Health Care AG (study performed by Bayer Schering Pharma AG)
Full Title: An open label, multi-center, phase 3 study with corresponding blinded image reading to determine the efficacy and safety of a single intravenous injection of 0.1 mmol/kg body weight of gadobutrol 1...
Medical condition: Patients with histologically confirmed breast cancer referred to MRM prior to surgery after XRM.
Disease: Version SOC Term Classification Code Term Level
12.0 10012992 Digital mammography LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed) FI (Completed) IT (Completed)
Trial results: View results
EudraCT Number: 2010-019962-10 Sponsor Protocol Number: P1-SAF301 Start Date:
Sponsor Name: SANFILIPPO Therapeutics SAS
Full Title: AN OPEN-LABEL, SINGLE ARM, MONOCENTRIC, PHASE I/II CLINICAL STUDY OF INTRACEREBRAL ADMINISTRATION OF ADENO-ASSOCIATED VIRAL VECTORS SEROTYPE 10 CARRYING THE HUMAN SGSH AND SUMF1 cDNAS FOR THE TREAT...
Medical condition: Sanfilippo type A syndrome (also named Mucopolysaccharidosis Type A)
Disease: Version SOC Term Classification Code Term Level
12.1 10056918 Sanfilippo's syndrome LLT
Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
Trial protocol: FR (Completed)
Trial results: (No results available)

EudraCT Number: 2018-001686-17 Sponsor Protocol Number: P170925J Start Date:
Sponsor Name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
Full Title:
Medical condition: Patients older than 15 years with hematologic or pulmonary lesions of telomeropathies.
Disease: Version SOC Term Classification Code Term Level
20.0 10010331 - Congenital, familial and genetic disorders 10062759 Congenital dyskeratosis PT
Population Age: Adolescents, Under 18 Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)
EudraCT Number: 2016-002526-36 Sponsor Protocol Number: PVO-1A-204 Start Date:
Sponsor Name: Clementia Pharmaceuticals Inc.
Full Title: A Phase 2, Open-Label, Efficacy and Safety Study of an RARγ-Specific Agonist (Palovarotene) to Prevent Heterotopic Ossification in Subjects with Fibrodysplasia Ossificans Progressiva (FOP)
Medical condition: Fibrodysplasia Ossificans Progressiva (FOP) is a rare, severely disabling disease characterized by painful, recurrent episodes of soft tissue swelling (flare-ups) and abnormal heterotopic ossificat...
Disease: Version SOC Term Classification Code Term Level
19.0 10010331 - Congenital, familial and genetic disorders 10068715 Fibrodysplasia ossificans progressiva PT
Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: FR (Completed)
Trial results: (No results available)

EudraCT Number: 2021-005314-34 Sponsor Protocol Number: SRK-015-003 Start Date:
Sponsor Name: Scholar Rock, Inc.
Full Title: Phase 3, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Apitegromab (SRK-015) in Patients with Later-Onset Spinal Muscular Atrophy Receiving Background Nusinersen or ...
Medical condition: Spinal Muscular Atrophy (SMA)
Disease: Version SOC Term Classification Code Term Level
20.1 100000004850 10041583 Spinal muscular atrophy, unspecified LLT
Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: BE (Ongoing) DE (Ongoing) ES (Ongoing) NL (Ongoing) PL (Ongoing)
Trial results: (No results available)
EudraCT Number: 2020-005522-28 Sponsor Protocol Number: ION363-CS1 Start Date:
Sponsor Name: Ionis Pharmaceuticals, Inc.
Full Title: A Phase 1-3 Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ION363 in Amyotrophic Lateral Sclerosis Patients with Fused in Sarcoma Mutati...
Medical condition: Amyotrophic Lateral Sclerosis with Fused in Sarcoma mutations
Disease: Version SOC Term Classification Code Term Level
21.1 10029205 - Nervous system disorders 10002026 Amyotrophic lateral sclerosis PT
Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: DE (Ongoing) IT (Ongoing) BE (Ongoing) NL (Ongoing) SE (Ongoing) IE (Ongoing) PL (Ongoing) ES (Ongoing)
Trial results: (No results available)

EudraCT Number: 2017-003638-10 Sponsor Protocol Number: 2016_37 Start Date:
Sponsor Name: CHRU LILLE
Full Title: INTRANASAL CLONIDINE PREDICTION IN PEDIATRIC SURGERY: RANDOMIZED STUDY AGAINST PLACEBO
Medical condition: intra-nasal premedication instead of oral, intravenous or no premedication.
Disease: Version SOC Term Classification Code Term Level
20.0 10042613 - Surgical and medical procedures 10042609 Surgery PT
Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)
EudraCT Number: 2005-000793-45 Sponsor Protocol Number: TMC114-C209 Start Date:
Sponsor Name: Tibotec Pharmaceuticals Ltd.
Full Title: Open-label safety study of TMC114 in combination with low dose RTV and other ARVs in highly experienced HIV-1 infected patients with limited or no treatment options.
Medical condition: HIV-1 infected patient
Disease: Version SOC Term Classification Code Term Level
7.1 10020161 4
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed) IT (Completed)
Trial results: View results

EudraCT Number: 2014-002195-90 Sponsor Protocol Number: SPON1334-14 Start Date:
Sponsor Name: Cardiff University
Full Title: Adults with acute myeloid leukaemia or high-risk myelodysplastic syndrome (AML19)
Medical condition: Acute myeloid leukaemia High Risk Myelodysplastic Syndrome (trial arm for this patient group is now closed awaiting final analysis)
Disease: Version SOC Term Classification Code Term Level
21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10028533 Myelodysplastic syndrome PT
21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10000880 Acute myeloid leukaemia PT
Population Age: Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: GB (GB - no longer in EU/EEA) DK (Completed)
Trial results: (No results available)
3